A Community-based Family Holistic Health Promotion Project in Hong Kong: A Cluster Randomized Controlled Trial (cRCT)
Launched by THE UNIVERSITY OF HONG KONG · Aug 10, 2016
Trial Information
Current as of April 25, 2025
Unknown status
Keywords
ClinConnect Summary
According to World Health Organization (WHO), the prevalence of obesity among all nations has nearly doubled since 1980. High body mass index (BMI) is one of the major risk factors of many non-communicable diseases (NCD) and is the result of unhealthy diet and physical inactivity. In Hong Kong, the Department of Health (DH) found in 2012, through the telephone surveys, that nearly 40% of adults were overweight or obese. About 60% of total registered deaths in Hong Kong were due to four major preventable NCD, which were cancer, heart diseases, stroke and chronic lower respiratory diseases. T...
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- 1. Train-the-trainers and ambassador programs:
- • Cantonese speaking
- • Intact verbal and hearing abilities for interpersonal communication
- • Reading and writing abilities for questionnaire completion
- • Community leaders and health ambassadors
- • Aged 18 or above
- 2. Community-based family interventions:
- • Cantonese speaking
- • Intact verbal and hearing abilities for interpersonal communication
- • Reading and writing abilities for questionnaire completion
- • Aged 12 or above
- 3. Public education events:
- • Reading and writing abilities for questionnaire completion
- • Aged 12 or above
- • Exclusion criteria
- • - Participants who fail to meet the inclusion criteria, or are unable to sign the consent form.
Trial Officials
Tai-hing Lam, MD
Principal Investigator
School of Public Health, The University of Hong Kong
Piana He, MSc
Study Director
Hong Kong Island Women Association
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong Island, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials